Astec LifeSciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	122.51	5.75	4.72	4.73	5.55
Cash & Short-Term Investments	122.51	5.75	4.72	4.73	5.55
Cash Growth	2029.11%	22.04%	-0.40%	-14.63%	63.67%
Accounts Receivable	2,477	1,474	1,690	1,549	2,736
Other Receivables	-	3.6	17.57	3.99	49.78
Receivables	2,503	1,506	1,708	1,553	2,788
Inventory	1,380	1,598	1,958	2,948	1,869
Prepaid Expenses	-	46.83	50.06	49.71	48.67
Other Current Assets	423.79	254.94	263.67	432.41	445.57
Total Current Assets	4,430	3,411	3,985	4,989	5,157
Property, Plant & Equipment	4,538	4,967	5,316	4,292	3,514
Long-Term Investments	0.05	0.05	0.05	0.05	0.05
Other Intangible Assets	247.55	234.49	194.16	159.04	113.9
Other Long-Term Assets	204.6	201.32	254.33	354.81	183.05
Total Assets	9,420	8,814	9,749	9,794	8,968
Accounts Payable	876.65	816.13	892.78	1,772	1,898
Accrued Expenses	-	14.56	20.08	16.51	12.55
Short-Term Debt	-	2,644	2,830	2,853	2,394
Current Portion of Long-Term Debt	3,989	101.76	119.37	450.39	400
Other Current Liabilities	131.91	81	109.79	170.46	201.32
Total Current Liabilities	4,998	3,657	3,972	5,262	4,906
Long-Term Debt	500	2,800	1,990	108.63	-
Pension & Post-Retirement Benefits	-	2.9	20.5	13.49	10
Long-Term Deferred Tax Liabilities	0.37	0.38	67.6	209.7	80.82
Other Long-Term Liabilities	12.96	3.67	4.42	4.78	4.28
Total Liabilities	5,511	6,464	6,054	5,599	5,001
Common Stock	222.82	196.11	196.09	196.06	195.98
Additional Paid-In Capital	-	613.92	610.9	607.36	603.48
Retained Earnings	-	1,536	2,882	3,386	3,162
Comprehensive Income & Other	3,683	1.27	3.89	3.83	3.07
Total Common Equity	3,906	2,347	3,693	4,194	3,965
Minority Interest	3.13	2.71	2.31	1.92	1.63
Shareholders' Equity	3,909	2,350	3,695	4,196	3,967
Total Liabilities & Equity	9,420	8,814	9,749	9,794	8,968
Total Debt	4,489	5,545	4,939	3,412	2,794
Net Cash (Debt)	-4,367	-5,540	-4,934	-3,407	-2,788
Net Cash Per Share	-203.94	-282.47	-251.61	-173.77	-142.26
Filing Date Shares Outstanding	22.29	19.61	19.61	19.61	19.6
Total Common Shares Outstanding	22.29	19.61	19.61	19.61	19.6
Working Capital	-567.95	-245.75	13.33	-273.47	250.89
Book Value Per Share	175.23	119.70	188.32	213.90	202.32
Tangible Book Value	3,659	2,113	3,499	4,035	3,851
Tangible Book Value Per Share	164.12	107.74	178.42	205.79	196.51
Buildings	-	2,040	1,700	1,290	1,286
Machinery	-	5,032	3,815	3,201	3,107
Construction In Progress	-	1.25	1,485	1,124	137.32

Source: S&P Global Market Intelligence. Standard template. Financial Sources.